ASO Author Reflections: Palliative Therapy Might be an Alternative When the Risks of Surgery for Perihilar Cholangiocarcinoma are High.
作者信息
Olthof Pim B, van Keulen Anne-Marleen, Buettner Stefan, Groot Koerkamp Bas
机构信息
Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
出版信息
Ann Surg Oncol. 2024 Oct;31(10):6569-6570. doi: 10.1245/s10434-024-15830-8. Epub 2024 Jul 16.
Abstract
摘要
相似文献
1
ASO Author Reflections: Palliative Therapy Might be an Alternative When the Risks of Surgery for Perihilar Cholangiocarcinoma are High.
Ann Surg Oncol. 2024 Oct;31(10):6569-6570. doi: 10.1245/s10434-024-15830-8. Epub 2024 Jul 16.
2
ASO Author Reflections: Surgical Strategy for Perihilar Cholangiocarcinoma.
Ann Surg Oncol. 2024 Jul;31(7):4454-4455. doi: 10.1245/s10434-024-15156-5. Epub 2024 Mar 6.
3
ASO Author Reflections: Benefits of Surgical Resection of Perihilar Cholangiocarcinoma with Positive Peritoneal Lavage Cytology.
Ann Surg Oncol. 2024 Sep;31(9):5645-5646. doi: 10.1245/s10434-024-15518-z. Epub 2024 May 23.
4
ASO Author Reflections: Expanding Minimally Invasive Options for Perihilar Cholangiocarcinoma: The Use of Robotic Platform in Biliovascular Reconstruction.
Ann Surg Oncol. 2024 Jul;31(7):4462-4463. doi: 10.1245/s10434-024-15385-8. Epub 2024 May 5.
5
ASO Author Reflections: Adequate Nodal Classification for Perihilar Cholangiocarcinoma.
Ann Surg Oncol. 2023 Jul;30(7):4318-4319. doi: 10.1245/s10434-023-13418-2. Epub 2023 Mar 31.
6
ASO Author Reflections: Robotic Approach for Perihilar Cholangiocarcinoma.
Ann Surg Oncol. 2024 May;31(5):3106-3107. doi: 10.1245/s10434-024-15006-4. Epub 2024 Feb 9.
7
ASO Author Reflections: Robotic Perihilar Cholangiocarcinoma Beyond Technical Feasibility.
Ann Surg Oncol. 2023 May;30(5):2834-2835. doi: 10.1245/s10434-023-13175-2. Epub 2023 Feb 25.
8
ASO Author Reflections: Importance of Preoperative Diagnosis of Lymph Node Metastasis in Perihilar Cholangiocarcinoma.
Ann Surg Oncol. 2022 Sep;29(9):5511-5512. doi: 10.1245/s10434-022-11933-2. Epub 2022 May 27.
9
ASO Author Reflections: Surgical Milestones in Hilar Cholangiocarcinoma: A Journey from Bismuth to the Future.
Ann Surg Oncol. 2024 Sep;31(9):5653-5654. doi: 10.1245/s10434-024-15581-6. Epub 2024 Jun 9.
10
Surgery for perihilar cholangiocarcinoma.
Br J Surg. 2018 Jun;105(7):771-772. doi: 10.1002/bjs.10875.
引用本文的文献
1
Tumor Biology Eventually Prevails in the Optimal Treatment of Perihilar Cholangiocarcinoma.
Ann Surg Oncol. 2024 Oct;31(10):6350-6351. doi: 10.1245/s10434-024-15868-8. Epub 2024 Jul 20.
本文引用的文献
1
Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk?
Br J Surg. 2023 Apr 12;110(5):599-605. doi: 10.1093/bjs/znad057.
2
Impact of Positive Lymph Nodes and Resection Margin Status on the Overall Survival of Patients with Resected Perihilar Cholangiocarcinoma: The ENSCCA Registry.
Cancers (Basel). 2022 May 12;14(10):2389. doi: 10.3390/cancers14102389.
3
Nationwide treatment and outcomes of perihilar cholangiocarcinoma.
Liver Int. 2021 Aug;41(8):1945-1953. doi: 10.1111/liv.14856. Epub 2021 Mar 12.
Zotero 插件